Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 3Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Depression 2Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Breast Neoplasms 1Breast Cancer Surgery 1Anxiety Disorders 1

Interventions

Therapeutics 21Psychiatric Rehabilitation 20Surveys and Questionnaires 7Early Intervention, Educational 6Counseling 6Yoga 5Psychosocial Intervention 5Cognitive Behavioral Therapy 5Behavior Therapy 5Mindfulness 4Ketamine 4Exercise 4Escitalopram 4Acupuncture Therapy 4Saline Solution 3Psilocybin 3Mindfulness-Based Stress Reduction 3Mindfulness-Based Cognitive Therapy 3Methods 3Exercise Therapy 3Control Groups 3Citalopram 3Chemotherapy, Adjuvant 3Sugars 2Sertraline 2Palliative Care 2Observation 2Niacin 2Mental Status and Dementia Tests 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Depression × Esketamine × Clear all
NCT06624878 2026-02-27

Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

Zhejiang Cancer Hospital

Phase NA Completed
568 enrolled
Gynecologic

Depression, Ovarian Neoplasms

NCT04850937 2022-07-28

Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

Yangzhou University

Phase NA Completed
90 enrolled

Depression, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡